2021 Emory Morningside Global Health Case Competition

2021 Emory Morningside Global Health Case Competition

Emory University and the Morningside Foundation have deepened their long partnership by collaborating on a multidisciplinary international student competition aimed at addressing real-world, critical global health challenges.

The contest has been renamed the Emory Morningside Global Health Case Competition, signifying a partnership and commitment to advance global health and train the next generation of global health leaders.

Read more about the partnership here

2021 Winning Teams

The Emory Global Health Institute’s (EGHI) 2021 Emory Morningside Global Health Case Competition challenged 52 multidisciplinary student teams from universities representing 15 countries and six continents to develop plans for COVID-19 vaccination programs that innovate solutions to overcome challenges such as vaccine hesitancy and inequitable distribution. This year’s case challenge asked student teams to design a country-wide vaccination program for one of four countries: Bangladesh, Brazil, Japan, or Nigeria. Teams were tasked with improving the public’s perception of the COVID-19 vaccines and ensuring that vaccines were adequately and appropriately distributed and administered to the public. Teams represented their selected country’s National Public Health Institute (NPHI) and presented their strategies to a panel of judges who played the role of members of the Vaccine Foundation, a fictional international organization focused on global health initiatives.

First Place

Duke Kunshan University

Hsien Yao Chee, Ie Huan Chong, Ege Kaan Duman, Remington Gillis, Thanaporn Thongtum, and Sage Wyatt

Second Place

Yeshiva University/Einstein-CUNY

Andrew Brook, Chetali Jain, Hanish Kodali, Heidi Sandomir, Alexandria Wilkins, and Scott Wilson

Third Place

University of Pittsburgh

Eva Brady, Emily Crisan, Naomi Gurewitsch, Haley Marra, Vishan Ramanathan, and Sophie Tayade

Fourth Place

Penn State University

Emma Baker, Brian Drury, Laura Guay, Krista Hartmann, Savanna Ledford, and Xingyan Wang

Fifth Place

Brown University

Franklin Iheanacho, Leah Jones, Emily O'Neill, Huijun Park, Hannah Peifer, and Alexander Philips

Sixth Place

University of Texas Southwestern

Kim Cury, Waqas Haque, Zara Khan, Bonnie Leung, Tra Ngo, and Virginia Wang

2021 Honorable Mention Teams

University of Lagos

Ibilola Cardoso-Daodu, Oluwafunmike Ogwa, Joseph Oiseoghaede, Uju Obi- Okafor, and Bukola Oseni

University of Minnesota

Jesse Abelson, Sarah Kenney, Paige Palomaki, Rees Parrish, Christopher Prokosch, and Kelly Reger

Universidad de los Andes

Miguel Angel Blanco Alvarado, Maria Jose Arango, Candace Julieth Forero, Luna Hurtado, Carlos José Macías Montenegro, and Gabriela Ríos

Notre Dame

Tyler Dann, Kyle Duffy, Morgan Foley, Leah Gudex, Matt Kozak, and Mason Sponem

Since vaccines were first invented, there has been mistrust and hesitancy in the general population about their safety and efficacy as well as problems with their equitable distribution. These issues continue today and have become more pronounced and problematic during the era of COVID-19. Now that several COVID-19 vaccines have been developed, shown to be safe and efficacious in clinical trials, and been made available in many countries under Emergency Use Authorization, the new challenge is to have both wide-spread global public acceptance and the equitable distribution of these vaccines.

Highly concerned about the situation, the Vaccine Foundation, a large international foundation focused on global health, has allocated a budget for a one-year project to address the challenge of improving the public’s perception of the vaccines and ensuring that vaccines are adequately and appropriately distributed and administered to the public, particularly in countries that have high rates of vaccine hesitancy. In addition to having a clear plan with a well-reasoned and justified budget, the winning proposal will also address vaccine hesitancy and the equitable distribution of vaccines in the entire country in which the plan is to be implemented. Evidence-based practices should inform the proposed country-based vaccination program. The proposed solution should consider how aspects of the political and legal environments, religion, and culture might play into the country’s existing vaccine hesitancy concerns and distribution plans as well as how to address those issues. It will also include a clear communications plan with culturally sensitive communications strategies.

Emory Morningside Global Health Case Competition teams selected one of the following countries for their proposed vaccination program: Bangladesh, Brazil, Japan, or Nigeria. The program budget was $100 million USD for each of the four countries ($100M USD/per country). Each EMGHCC team represented their selected country’s National Public Health Institute (NPHI). Teams pitched their NPHI’s proposal to the Vaccine Foundation on behalf of their country.

First-Round Judges

Mehul Bhagat - Founder, Mystro and Entrepreneur in Residence, The New School

Timothy Brewer, MD, MPH - Professor, Fielding School of Public Health, University of California at Los Angeles

Michael Carrasco - Managing Director, Alvarez & Marsal

Stephen Cochi, MD - Senior Advisor to the Director, Global Immunization Division, Center for Global Health, CDC

Scott Colcord - Senior Director, Alvarez & Marsal

George Hardy, MD, MPH - Former Executive Director, Association of State and Territorial Health Officials

Lenka Hennessy - Director, Alvarez & Marsal

Augustus Hudson, MS, PMP, MEP, CM, ACE - Director of Emergency Management and Communications, Hartsfield-Jackson Atlanta International Airport

Angela Blair Hutchinson, PhD, MPH - Senior Health Economist, CDC

Phil Jacobs - Founding Partner, Pendleton Consulting Group

Erik Josephson, MA - Health Economist

Richard Kellogg, MS - Founder and Former Director, Laboratory Response Network for Bioterrorism Preparedness and Emergency Response, CDC

Kate Koplan, MD, MPH, FACP, CPPS - Associate Medical Director of Quality and Patient Safety, Kaiser Permanente

Vincent C. Marconi, MD - Professor, Emory University School of Medicine

John Oliphant, PhD, MHP, PA-C, MSEd - Associate Professor, Institute of Health Sciences and Technology, Rochester Institute of Technology

Walter A. Orenstein, MD - Professor, Emory University School of Medicine

Robert W. Pinner, MD - Associate Director for Programs, Surveillance, & Informatics, National Center for Emerging and Zoonotic Infectious Diseases, CDC

Vince Radke, MPH - Former Deputy Director, Environmental Health Services Branch of the National Center for Environmental Health at CDC

Richard Skolnik, MPA - Former Director for Health and Education, South Asia Region, World Bank

Arjun Srinivasan, MD - Associate Director for Healthcare-Associated Infection Prevention Programs, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC

Julie Swann, PhD - Department Head and A. Doug Allison Distinguished Professor of the Fitts Department of Industrial and Systems Engineering, North Carolina State University

Brian Zanoni, MD, MPH - Assistant Professor, Emory University School of Medicine

Final-Round Judges

Zulfiqar Bhutta, MBBS, PhD - Robert Harding Inaugural Chair in Global Child Health, Hospital for Sick Children, Toronto

Claire Broome, MD - Former US Assistant Surgeon General and Acting Director of the CDC

Keiji Fukuda, MD, MPH - Director and Clinical Professor, Division of Community Medicine and Public Health Practice, University of Hong Kong School of Public Health

Phil Jacobs - Founding Partner, Pendleton Consulting Group

Portia Mutevedzi, PhD, MSc - Senior Epidemiologist at the MRC Respiratory and Meningeal Pathogens Research Unit, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa